Exogenous CD19 stimulation in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy, sequential rapid immune-assay in heparin-induced thrombocytopenia diagnosis, and new survival prediction models for chronic myelomonocytic leukemia
Blood Podcast
00:00
Intro
This chapter explores the efficacy of CD19 CAR T-cell therapy for treating B-cell acute lymphoblastic leukemia, highlighting findings from early phase clinical trials. It also discusses the development of algorithms to enhance the diagnosis of heparin-induced thrombocytopenia, aiming to improve patient management.
Transcript
Play full episode
